维普中文期刊产品整合服务
17篇 您的检索式:作者名="Hanafy D"
    题名 作者 年代 出处 被引量
1IP Virtual Private Networks 显示文摘Hills S McGlaughlin D Hanafi N 2000BT Technology Journal2000,18,3:1
2Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound 显示文摘Langguth P Hanafy A Frenzel D 2005Drug Dev IndPharm2005,31,3:1
3Surface properties of silica produced by thermal treatment of rice husk ash 显示文摘HANAFI S ABO-EL-ENEIN S A IBRAHIM D M 1980ThermochimActa1980,37,:1
4Intestinal drug efflux:formulation and food effects 显示文摘Wagner D Spahn-Langguth H Hanafy A 2001Adv Drug Deliv Rew2001,50,1:1
5reversible pulmonary hypertension in heart transplant candidates pretransplant evaluation and outcome after orthotopic heart transplantation显示文摘Klotz S Deng MC Hanafy D 2003Eur J heart failure2003,,5:1
6Nanosuspension formulations for low-soluble drugs:pharmacokinetic evaluation using spironolactone as model compound显示文摘Langguth P Hanafy A Frenzel D 2005Drug Dev Ind Pharm2005,31,3:1
7Intestinal drug efflux: formulation and food effects显示文摘WAGNER D SPAHN-LANGGUTH H HANAFY A 2001Adr Drug Deliv Rew2001,50,1:1
8Inteslinal drug effluxformulation and food effects显示文摘WAGNER D SPAHN-LANGGNTH H HANAFY A 2001Adv Drug Deliv Rev2001,50,1:1
9Intestinal drugefflux:formulation and food effects显示文摘Wagner D Spahn-Langguth H Hanafy A 2001Adv Drug Deliv Rev2001,50,1:1
10Nanosuspension formulations for low-soluble drugs:pharmacokinetic evaluation using spironolactone as model compound显示文摘LANGGUTH P HANAFY A FRENAEL D 2005Drug Dev Ind Pharm2005,31,:1
11Nanosuspension formulations for low-soluble drugs:pharmacokinetic evaluation using spironolactone as model compound显示文摘LANGGUTH P HANAFY A FRENZEL D 2005Drug Dev Ind Pharm2005,31,:1
12Intestinal drug efflux:formulation and food effects 显示文摘 Spahn-Langguth H Hanafy A 2001Adv Drug Deliv Rev2001,50,1:1
13Intestinal drug efflux: formulation and food effects 显示文摘Wagner D Spahn Langguth H Hanafy A 2001Advanced drug delivery reviews2001,50,:1
14Nanosuspension formulations for low-soluble drugs:pharmacokinetic evaluation using spironolactone as model compound显示文摘Langguth P Hanafy A Frenzel D 2005Drug Dev Ind Pharm2005,31,3:1
15Intestinal drug efflux: formulation and food effects显示文摘Wagner D Spahn-Langguth H Hanafy A 2001Adv Drug Deliv Rev2001,50,1:1
16Nanosuspension formulationsfor low-soluble drugs: pharmacokinetic evaluation using spironolacto-ne as model compound显示文摘Langguth P Hanafy A Frenzel D 2005Drug Dev Ind Pharm2005,31,3:1
17Curing characteristics and mechanical properties of short oil palm fibre reinforced rubber composites显示文摘Hanafi Ismail Rosnah N Rozman H D 1997Polymer1997,38,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费